Bioregenx BRGX
OTC BRGX
$0.00 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Bioregenx, Inc. (BRGX) Accumulated Expenses (2023 - 2026)

Updated

Bioregenx (BRGX) recorded Accumulated Expenses of $386,754 in Q1 2026, down 24.8% from $514,531 a year earlier and down 11.0% from the prior quarter.

Analysis

Bioregenx, Inc. (BRGX) Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Bioregenx reported Accumulated Expenses of $434,370, down 4.1% from FY2024.

  • Across earlier years, Accumulated Expenses came in at $452,960 in FY2024 (+30.7%) and $346,677 in FY2023.
  • Quarterly Accumulated Expenses has ranged from $346,677 in Q4 2023 to $514,531 in Q1 2025 over the past five years.
  • On a year-over-year basis, Accumulated Expenses has declined for three consecutive quarters, with growth averaging 5.8% over the last six quarters.
  • Per Business Quant, the preceding three quarters came in at $434,370 (Q4 2025), $380,599 (Q3 2025) and $405,495 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 386,754.00
Dec 31, 2025 434,370.00
Sep 30, 2025 380,599.00
Jun 30, 2025 405,495.00
Mar 31, 2025 514,531.00
Dec 31, 2024 452,960.00
Sep 30, 2024 426,725.00
Jun 30, 2024 398,058.00
Mar 31, 2024 684,584.00
Dec 31, 2023 346,677.00
API Access

Bioregenx, Inc. Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BRGX&period=max&api_key=YOUR_API_KEY